The Categorization of Perinatal Derivatives for Orthopedic Applications
-
Published:2024-07-11
Issue:7
Volume:12
Page:1544
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Trivedi Amol H.12ORCID, Wang Vicki Z.1, McClain Edward J.1ORCID, Vyas Praveer S.1, Swink Isaac R.1, Snell Edward D.1, Cheng Boyle C.1ORCID, DeMeo Patrick J.1
Affiliation:
1. Orthopaedic Institute, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA 15212, USA 2. Drexel University College of Medicine, Drexel University, University City Campus, Philadelphia, PA 19104, USA
Abstract
Musculoskeletal (MSK) pathology encompasses an array of conditions that can cause anything from mild discomfort to permanent injury. Their prevalence and impact on disability have sparked interest in more effective treatments, particularly within orthopedics. As a result, the human placenta has come into focus within regenerative medicine as a perinatal derivative (PnD). These biologics are sourced from components of the placenta, each possessing a unique composition of collagens, proteins, and factors believed to aid in healing and regeneration. This review aims to explore the current literature on PnD biologics and their potential benefits for treating various MSK pathologies. We delve into different types of PnDs and their healing effects on muscles, tendons, bones, cartilage, ligaments, and nerves. Our discussions highlight the crucial role of immune modulation in the healing process for each condition. PnDs have been observed to influence the balance between anti- and pro-inflammatory factors and, in some cases, act as biologic scaffolds for tissue growth. Additionally, we assess the range of PnDs available, while also addressing gaps in our understanding, particularly regarding biologic processing methods. Although certain PnD biologics have varying levels of support in orthopedic literature, further clinical investigations are necessary to fully evaluate their impact on human patients.
Reference145 articles.
1. Global burden of musculoskeletal disorders and attributable factors in 204 countries and territories: A secondary analysis of the Global Burden of Disease 2019 study;Liu;BMJ Open,2022 2. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019;Wu;Lancet Healthy Longev.,2021 3. Silini, A.R., Di Pietro, R., Lang-Olip, I., Alviano, F., Banerjee, A., Basile, M., Borutinskaite, V., Eissner, G., Gellhaus, A., and Giebel, B. (2020). Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature. Front. Bioeng. Biotechnol., 8. 4. Roy, A., Mantay, M., Brannan, C., and Griffiths, S. (2022). Placental Tissues as Biomaterials in Regenerative Medicine. BioMed Res. Int., 2022. 5. Protzman, N.M., Mao, Y., Long, D., Sivalenka, R., Gosiewska, A., Hariri, R.J., and Brigido, S.A. (2023). Placental-Derived Biomaterials and Their Application to Wound Healing: A Review. Bioengineering, 10.
|
|